Skip to main content
MEDICLINIC INTERNATIONAL PLC logo

MEDICLINIC INTERNATIONAL PLC — Investor Relations & Filings

Ticker · MDC ISIN · US58471Q1004 LEI · 2138002S5BSBIZTD5I60 IL Human health and social work activities
Open in API
Filings indexed 628 across all filing types
Latest filing 2022-12-23 M&A Activity
Country GB United Kingdom
Listing IL MDC

About MEDICLINIC INTERNATIONAL PLC

https://www.mediclinic.com/en/home.html

Mediclinic International PLC is a diversified international private healthcare services group focused on providing specialist-orientated, multi-disciplinary services across the continuum of care. The company's clinical offerings include acute care, outpatient consultations, pre-hospital emergency services, day case surgery, and inpatient care. With a core purpose to enhance the quality of life, the group emphasizes delivering high-quality, patient-centric healthcare. Mediclinic operates with a sustainable, long-term approach, upholding high standards of clinical governance and investing in skilled professionals, advanced facilities, and modern medical equipment to be a trusted provider for clients, medical practitioners, and funders.

Recent filings

Filing Released Lang Actions
Form 8.3 - Mediclinic International plc
M&A Activity Classification · 1% confidence The document is explicitly titled "FORM 8.3 - Mediclinic International plc" and references "Rule 8.3 of the Takeover Code (the “Code”)". This form is a Public Opening Position Disclosure or Dealing Disclosure made by a person holding 1% or more interests in relevant securities during a takeover situation. This type of disclosure relates specifically to insider/major shareholder activity during a takeover bid, which falls under the scope of M&A activity or specific regulatory disclosures related to takeovers. Since there is a specific category for M&A Activity (TAR), and this filing is directly related to a takeover situation involving Mediclinic International plc, TAR is the most appropriate classification. It is not a general Director's Dealing (DIRS) as it is tied to a specific takeover code disclosure (Form 8.3), nor is it a general Regulatory Filing (RNS) because TAR is more specific to the context.
2022-12-23 English
Form 8.3 - Mediclinic International plc
Major Shareholding Notification Classification · 1% confidence The document is explicitly titled 'FORM 8.3 - PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' and references 'Rule 8.3 of the Takeover Code (the “Code”)'. This form is used in the context of a takeover offer (Mediclinic International plc is the offeree) to disclose a person's (Millennium International Management LP) interests and dealings in the relevant securities. This type of disclosure relates directly to insider/significant shareholder activity during a takeover scenario. While it involves director/executive dealings in a broad sense, the specific context of a takeover disclosure (Rule 8.3) is not explicitly covered by DIRS (Director's Dealing) or MRQ (Major Shareholding Notification). However, since it details personal share transactions/interests by a major party involved in a takeover, it is most closely related to insider trading/dealing disclosures. Given the options, 'Director's Dealing' (DIRS) is the closest fit for reporting personal security interests/transactions by a major stakeholder, although 'Takeover Activity' (TAR) is also relevant. Since this is a mandatory disclosure related to a potential takeover (which often involves M&A activity), and the document details positions and dealings of a party involved in the offer, TAR (M&A Activity) is a strong candidate, but DIRS specifically covers personal share transactions by executives/directors. Rule 8.3 disclosures are specifically about parties to an offer. Since the document details dealings and positions related to an offer, and the definitions do not have a specific 'Takeover Disclosure' code, we must choose the best fit. DIRS covers director/executive trades. MRQ covers major shareholding changes. Given the context of a takeover offer and the detailed nature of the position disclosure, it is highly specific to the M&A process. I will classify this as TAR (M&A Activity) because Form 8.3 is intrinsically linked to a takeover bid, which falls under the scope of M&A activity, rather than routine director dealing (DIRS) or general shareholding changes (MRQ).
2022-12-22 English
Form 8.3 - Mediclinic International plc
M&A Activity Classification · 1% confidence The document is explicitly titled 'FORM 8.3 - Mediclinic International plc' and references 'Rule 8.3 of the Takeover Code (the “Code”)'. This form is a Public Opening Position Disclosure/Dealing Disclosure made by a person holding 1% or more interests in relevant securities during a takeover situation. This type of filing relates directly to insider transactions or significant ownership changes during a takeover bid, which falls under the scope of M&A activity or specific regulatory disclosures related to takeovers. Since there is a specific category for M&A Activity (TAR), and this document is a direct consequence of a takeover situation (as indicated by the reference to the Takeover Code and the disclosure of interests in securities related to an offeror/offeree), TAR is the most appropriate classification. It is not a general Director's Dealing (DIRS) as it is specifically tied to a takeover event under the Takeover Code rules.
2022-12-21 English
Form 8.3 - Mediclinic International plc
M&A Activity Classification · 1% confidence The document is explicitly titled 'FORM 8.3 - Mediclinic International plc' and references 'Rule 8.3 of the Takeover Code (the “Code”)'. This form is a mandatory disclosure required when a person holding 1% or more in relevant securities makes a dealing or holds an opening position during a takeover offer. This type of disclosure relates to insider dealings or significant ownership changes during a takeover scenario. While it involves director/insider activity (like DIRS), the specific context of the Takeover Code (Rule 8.3) points towards a specialized filing related to M&A activity or significant ownership changes during a bid. Given the options, this is most closely related to M&A Activity (TAR) or potentially a specific type of Director's Dealing (DIRS) or Regulatory Filing (RNS). However, Form 8.3 is a specific disclosure mandated by the UK Takeover Panel during a takeover situation. Since 'TAR' covers M&A activity, and this disclosure is a direct consequence of a potential or ongoing takeover bid involving Mediclinic, TAR is the most appropriate classification, as it deals with the mechanics of a takeover bid. If TAR were not available, DIRS or RNS would be considered, but TAR captures the context best.
2022-12-20 English
Form 8.3 - Mediclinic International plc
Major Shareholding Notification Classification · 1% confidence The document is explicitly titled 'FORM 8.3 - Mediclinic International plc' and references 'Rule 8.3 of the Takeover Code (the “Code”)'. This form is a Public Opening Position Disclosure/Dealing Disclosure made by a person holding 1% or more interests in relevant securities during a takeover situation. This type of disclosure relates to insider/significant shareholder activity during a takeover bid, which falls under the scope of M&A activity or significant shareholding notification, but the specific nature of reporting director/insider dealings related to a takeover is best captured by the 'Director's Dealing' (DIRS) category, as it tracks personal transactions/interests of parties involved in the offer, or more broadly, the 'Major Shareholding Notification' (MRQ) if the filer is not a director but a major shareholder disclosing position changes during an offer. Given the context of 'Rule 8.3 of the Takeover Code', this is a mandatory disclosure related to a takeover bid. While 'TAR' (M&A Activity) is relevant, Form 8.3 is specifically about disclosing interests/dealings. Since the definitions do not have a specific 'Takeover Disclosure' code, we must choose the closest fit. Form 8.3 discloses the position and dealings of a person with interests in securities related to an offer. This is highly specific insider/major shareholder activity during a corporate action. 'DIRS' covers director dealing, and 'MRQ' covers major shareholding notifications. Since this is a mandatory disclosure related to a takeover bid concerning a significant holding (1%+), and it details the position and dealings of an interested party, it aligns closely with tracking significant ownership changes during a corporate event. However, the closest fit among the provided options for mandatory disclosure of personal security interests/dealings by a significant party during a corporate action is often grouped with insider transactions or major shareholding changes. Given the explicit reference to 'interests in relevant securities representing 1% or more' during a takeover context, 'MRQ' (Major Shareholding Notification) is a strong candidate, as is 'DIRS' if the filer were a director. Since the filer is 'Millennium International Management LP' (an investment manager), 'MRQ' is more appropriate than 'DIRS'. However, the document is fundamentally about reporting dealings/positions during a takeover, which is a specific type of M&A event. Let's re-evaluate the options: DIRS (Director's Dealing), MRQ (Major Shareholding Notification), TAR (M&A Activity). Since this is a mandatory disclosure under the Takeover Code, it is a regulatory filing related to M&A. If we must choose one, 'TAR' covers the context (takeover), but 'MRQ' covers the mechanism (reporting a significant holding change). In many classification schemes, takeover disclosures are distinct. Given the options, 'TAR' (M&A Activity) captures the underlying event driving the filing, while 'MRQ' captures the nature of the disclosure (significant holding). Since the document is a direct consequence of a takeover bid (Mediclinic International plc), 'TAR' is the most contextually accurate classification for a Form 8.3 filing.
2022-12-19 English
Form 8.3 - Mediclinic International plc
M&A Activity Classification · 1% confidence The document is explicitly titled 'Form 8.3 - Mediclinic International plc' and references 'Rule 8.3 of the Takeover Code (the “Code”)'. This form is a Public Opening Position Disclosure/Dealing Disclosure made by a person holding 1% or more interests in relevant securities during a takeover situation. This type of disclosure relates to insider transactions or significant ownership changes during a takeover/merger event. Among the provided codes, 'TAR' (M&A Activity) is the most appropriate category as it covers merger proposals or takeover bids, which necessitate these specific disclosures under the Takeover Code. It is not a standard regulatory filing (RNS) or a Director's Dealing report (DIRS), as it is specifically tied to the rules governing takeover offers.
2022-12-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.